Log in with your email address username.


[Comment] Continuous glucose monitoring: transforming diabetes management step by step

The introduction and evolution of continuous glucose monitoring (CGM) has transformed how glucose control is defined and approached. Glycated haemoglobin (HbA1c) remains the key surrogate for the risk of microvascular complications and a good comparator of average glycaemic control in different populations. But use of HbA1c alone to guide diabetes management can be misleading.1 With the high clinical burden and cost associated with substantial hypoglycaemia,2 a better approach to optimal glycaemic management might be HbA1c combined with a measure of hypoglycaemia.